Is HCA Healthcare (HCA) a risky stock?
As of July 27, 2026, Clavix grades HCA Healthcare (HCA) D for risk, a composite score of 42 out of 100 on an A+ to F scale, which puts HCA in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
HCA price, last 3 months
HCA's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind HCA's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how HCA scores on each, as of July 27, 2026.
What's moving HCA's risk right now
Company-specific signals Clavix flags behind HCA's current grade, drawn from recent news and filings as of July 27, 2026.
Bragar Eagel & Squire, Kirby McInerney, and Kessler Topaz Meltzer & Check are investigating HCA over potential securities claims tied to recent weak financial results. No wrongdoing has been alleged, but the probes could lead to class-action lawsuits, added legal costs, and management distraction.
Higher expenses and weaker outpatient volumes could offset gains from inpatient admission growth in HCA's upcoming Q2 results. Rising costs may squeeze margins heading into the print, though inpatient growth offers some offset to the pressure.
Recent HCA news
The latest headlines Clavix ingested for HCA Healthcare, newest first. These feed the news-sentiment dimension of HCA's grade.
What a D grade means
On the Clavix A+ to F scale, HCA's composite of 42 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell HCA or any security. Grades are risk indicators, not predictions of return. Data may be delayed.